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Abstract  
The aim of this study was to measure the prevalence of HIV infection and assess the level 
of equipment- sharing and unsafe sexual activity among attendees at a Dublin needle 
exchange. Using an anonymous unlinked approach, attendees were asked to complete a 
brief questionnaire and provide a sample of saliva for HIV testing. Of the 144 attendees 
eligible for inclusion during the study period, 106 agreed to participate and complete a 
questionnaire, a response rate of 74%. Of the 81 respondents who submitted a usable 
saliva sample, 14.8% were HIV positive. Half of the respondents claimed that they had not 
shared equipment during the preceding 28 days, but a third had shared with multiple 
partners. Half of the respondents claimed that they had multiple sexual partners during the 
preceding year, but only a quarter said that they always used condoms. The prevalence of 
HIV infection is similar to that found m routine linked testing of drug users in Ireland. The 
high level of unsafe injecting and sexual activity makes clear the need for more effective 
health promotion among drug users in Dublin.  
Introduction  
Ireland has a much higher proportion of HIV transmission due to intravenous drug abuse 
than is the case in many other European countries, and a large proportion of this problem 
occurs in Dublin. Over 40% of AIDS cases in Ireland are associated with intravenous drug 
abuse1.
 
In order to address this situation, the Eastern Health Board set up a needle-
exchange programme in mid-1989. The response in terms of the number of people 
attending the exchange was good. By the end of 1990 approximately 630 individuals had 
attended the exchange and there had been approximately 3200 attendances in all. At this 
stage it was felt necessary to evaluate the exchange in a more formal way. The aim of this 
study was to measure the prevalence of HIV infection and assess the level of equipment-
sharing and unsafe sexual activity among attendees at a Dublin needle exchange. This 
data will provide a baseline for on-going monitoring of the effect of the needle-exchange 
service.  
Methods  
Using a protocol devised by the Public Health Laboratory Service AIDS Centre, Colindale, 
London,2
 
all attendees at the exchange during a 6-week period in February-March 1991 
were asked to supply a sample of saliva for HIV testing and to complete a brief self-
administered questionnaire. Participation was voluntary and both saliva and questionnaire 
were anonymous but linked together by a common code number. This study design meant 
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that it was not possible to attribute the results of HIV testing to individuals, but serological 
testing with full counselling was available for people wishing to find out their antibody 
status.  
 
The one-page questionnaire included questions on age, sex, previous HIV testing, 
frequency of injecting, drugs used, needle and syringe sharing, number of sexual partners 
and condom usage. HIV testing was via y antibody capture enzyme-linked immunosorbent 
assay (GAC ELISA) capture. The test materials were from prototype kits supplied by Dr J. 
Parry, Virus Reference Laboratory, Public Health Laboratory Service, Colindale.  
 
Statistical analysis was done using the SAS® System, Version 6.06 (SAS Institute, Cary, 
North Carolina). The chi-squared test was used for comparison of proportions and the 
Wilcoxon rank sum test was used for comparison of medians. Student’s t-test was used for 
comparing means. Differences not significant at the 5% level are indicated by (NS).  
During the study period, 144 people attending the centre were eligible for inclusion in the 
study and 106 participated, a response rate of 74%. All clients attending the centre during 
the study period were eligible for inclusion provided that they had not previously been 
asked to participate – thus the only exclusion criterion was having participated or declined 
to participate on a prior occasion during the study period.  
Results  
Table 1. Needle-sharing behaviour of respondents during month preceding survey  
 Needle-borrowing practices  
Needle-lending practices None 1 partner 2 or more partners  Total  
None  
1 partner  
2 or more partners  
Total  
35 (46.1%)  
2 (2.6%)  
2 (2.6%)  
39 (51.3%)  
4 (5.3%)  
7 (9.2%)  
0 (0.0%)  
11 (14.5%)  
1 (1.3%)  
1 (1.3%)  
24 (31.6%)  
26 (34.2%)  
40 (52.6%)  
10 (13.2%)  
26 (34.2%)  
76 (100.0%)  
Percentages refer to percentage of the total (76).  
 
Sex of respondent was available on 104 cases, 80 males and 24 females (male-female 
ratio was 3.3:1). The median age of the males was 28 years (range 18–40) and that of 
females was 27 (range 19–36). The median age of starting to inject drugs was 19 (range 
6–36). The drug used most often during the 28 days preceding the survey was MST 
(morphine sulphate)–it had been used by 48.1% of respondents. Next most frequent was 
heroin, which had been used by 34.9%. Of the 106 persons who participated in the study, 
76 responded to questions on needle-sharing while 30 did not. There was a similar 
proportion of males among responders 57/76 (75%) and non-responders 24/29 (82.8%) 
(NS). The mean age of responders was 29.0 years and that of non-responders was 29.8 
years (NS). The mean age of starting intravenous drug use was 20.1 years for responders 
and 25.7 years for non-responders (NS).  
 
Table 1 shows the needle-sharing practices during the month preceding the survey of the 
76 respondents who replied to the questions on sharing. Of these, nearly half shared with 
no one else but over a third shared with two or more other people. Although 27/60 (45%) 
of males reported no sharing of needles compared with 11/20 (55%) of females this 
difference was not statistically significant. As regards age, 22/53 (41.5%) of respondents 
aged under 30 reported no sharing compared with 15/26 (57.7%) of those aged over 30 
(NS). Table 1 distinguishes between needle-lending and needle-borrowing. Of the 40 
respondents who claimed not to have lent needles during the preceding month, 5 or 12.5% 
had borrowed from others. Of the 39 who claimed not to have borrowed during the 
preceding month, four (10.3%) had lent needles to others.  
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Table 2. Condom-usage of respondents in relation to HIV status  
 HIV status  
 Positive Negative Total 
Condom usage n (%) n (%) n (%) 
Always  
Sometimes  
Never  
Total  
3 
5 
2 
10 
(30.0) 
(50.0) 
(20.0) 
(100.0) 
14 
26 
20 
60 
(23.3) 
(43.3) 
(33.3) 
(100.0) 
17 
31 
22 
70 
(24.3) 
(44.3) 
(31.4) 
(100.0) 
X2
 
= 0.73 (2 df) p = 0.7.  
 
As regards sexual activity, respondents were asked the following question: in the last year, 
have you had sexual intercourse (vaginal or anal)? Some 99 respondents answered the 
question and 92 of these (92.9%) had seen sexually active during the preceding year. 
Those who answered yes to the above question were asked the following questions: if 
yes, with how many different men? and with how many different women? Seventy-six 
respondents provided information on their number of sexual partners. Forty-one of these 
(53.9%) claimed to have had one partner only and 35 (46.1%) claimed to have had more 
than one. Of the 19 male respondents who answered the question on number of male 
partners, two claimed that they had had one or more male partners during the preceding 
year.  
 
As regards condom use, 88 respondents answered the question but only 21 (23.9%) 
claimed to use condoms always, with 41 (46.6%) using them sometimes and 26 (29.5%) 
never using them.  
 
A usable sample of saliva was obtained from 81 respondents and of these 12 (14.8%) 
were HIV positive. Eighteen per cent of males (11/61) and 5.3% of females (1/19) were 
HIV positive (NS). As regards age group, 14.8% (8/54) of those under 30 were HIV 
positive compared with 16% (4/25) of those over 30 (NS).  
 
Seventy-seven of those tested for HIV answered the question on sexual intercourse during 
the preceding year. Of the HIV positive cases, 10/11 had been sexually active compared 
with 60/66 of those who were HIV negative (NS).  
 
Fifty-nine of those tested for HIV answered the question on number of sexual partners 
during the preceding year. Of those HIV positive and sexually active, 5/9 (55.5%) had had 
more than one partner compared with 20/50 (40.0%) of those who were HIV negative 
(NS).  
 
Seventy of those tested for HIV answered the question on condom use and Table 2 
reveals that only 30% of those who were HIV positive claimed to have used condoms 
always.  
 
Table 3 shows that 80% of HIV positive respondents shared needles compared with 51% 
of HIV negatives (NS). The median number of years since commencement of injecting 
drugs was 9 for both HIV positive and HIV negative respondents (NS).  
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Table 3. Needle-sharing practices of respondents in relation to HIV status  
  HIV status  
 Positive Negative Total 
No. of sharing partners n (%) n (%) n (%) 
None  
1 partner  
2 or more partners  
Total  
2 
2 
6 
10 
(20.0) 
(20.0) 
(60.0) 
(100.0) 
26 
9 
18 
53 
(49.0) 
(17.0) 
(34.0) 
(100.0) 
28 
11 
24 
63 
(44.4) 
(17.5) 
(38.1) 
(100.0) 
X2
 
= 3.14 (2 df) p = 0.2.  
Discussion  
This is the first anonymous unlinked study of HIV prevalence among Irish intravenous drug 
users, and also the first Irish study to employ salivary testing. The response rate of 74% 
was reasonably good, but the fact that a usable sample of saliva was only obtained from 
81 people (76% of respondents but 56% of attendees) was disappointing as intensive 
efforts were made by the staff to recruit as many attendees as possible. Every attempt 
was made to reassure them about the anonymous unlinked nature of the study, and to 
explain clearly the saliva collection procedure.  
 
Our results suggest that approximately one person in six attending the Dublin exchange 
was HIV positive, a level similar to that revealed by routine linked HIV testing of drug users 
in Ireland. This finding should be regarded with some caution in the light of the relatively 
poor uptake of saliva testing among the total sample. It is possible that attendees who 
knew themselves  
 
to be HIV positive might have been less likely to participate in the study or to provide a 
usable sample of saliva, and thus the true prevalence of HIV may be substantially higher 
than 14.8%. If the 63 drug users who attended the needle- exchange during the study 
period but failed to submit a saliva sample were all HIV positive, then the seroprevalence 
could be as high as 52%. On the other hand, if they were all negative the seroprevalence 
would be 8.3%. However, the prevalence of HIV antibodies in this population is definitely 
higher than the rate of 2.4% found in a study carried out at a needle-exchange in London 
which employed a similar methodology to ours3
 
but which had a response rate of 89%. In 
Edinburgh in 1988 it was found that 36.5% of 104 intravenous drug users attending the 
Community Drug problem Service were HIV positive. However, less than half of all 
attendees were tested.4
 
A city-wide study in Edinburgh involving HIV testing of saliva from 
226 drug users found 20.4% to be HIV positive.5
 
in Dundee, five out of 13 known drug 
users (38.5%) in a necropsy series were HIV positive.6
 
In 1990 a large study involving over 
500 drug users in Glasgow and using saliva testing found that 1.1% were HIV positive. 
The response rate in this study was over 90%.7
 
 
 
Although we have no information as to when HIV infection may have occurred among 
those found to be HIV positive, the fact that respondents, both HIV positive and HIV 
negative, reported recent unsafe needle and sexual practices is disturbing and suggests 
that the virus may continue to spread at a significant rate among the attendees and their 
contacts. Needle/syringe-sharing is especially dangerous,8
 
and the fact that 60% of HIV 
positive respondents and 34% of HIV negative respondents had recently shared 
equipment with two or more partners, despite freely available clean works and intensive 
counselling must cause serious concern. However, it is quite possible that an even higher 
level of needle-sharing would prevail if the exchange did not exist. It is encouraging to note 
that 46.1% of respondents in our study reported no equipment-sharing as compared to 
36% of those in the London study.3
 
However, a lower reported prevalence of needle-
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sharing in Glasgow (7%) than in Dublin may help to explain why HIV prevalence among 
drug users in that city appears to be much lower than in Dublin.7
 
Needle- sharing seems to 
be declining in Edinburgh,5,9,10
 
and we hope to repeat our study in 1994 in order to see 
whether a similar trend is occurring in Dublin.  
 
The finding that nearly half of the respondents (46.1%) and 55.5% of those who were HIV 
positive, claimed to have had more than one sexual partner during the preceding 12 
months is also disturbing. The risk of getting HIV infection via sexual contact is somewhat 
lower than that from equipment-sharing but is nevertheless very substantial.8
 
In the 
London study 25% of respondents reported multiple sexual partners, but the question 
referred only to the 3 months prior to the study.3
  
 
A quarter of the respondents in our study reported using condoms always, but a third 
never used them. This level of usage is fairly similar to that found among drug users in 
New York,11
 
and while it may slow down the sexual transmission of HIV infection, it will 
certainly not eliminate it. A recent review of condoms usage suggested that the attitude of 
the French essayist de Montaigne who in the 16th century described condoms as “armour 
against enjoyment, gossamer against infection” is still the predominant view today.12
 
However, it was suggested that these attitudes may be modifiable, especially by health 
professionals.  
 
Despite the limitations of the present study, it does provide a valuable snapshot of the 
level of HIV infection and risk behaviour among needle-exchange attendees in Dublin. Its 
most import- ant benefit will be to provide a baseline against which the effectiveness of the 
needle-exchange can be measured by carrying out periodic studies using the same 
methodology. It also shows the need for new and more effective strategies designed to 
promote safer drug usage and sexual activity among drug users.  
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